NCT07850440

Brief Summary

High perianal fistulae involve a significant portion of the external anal sphincter muscle, making standard surgical fistulotomy risky due to the potential for postoperative fecal incontinence. Sphincter-preserving techniques aim to eradicate the fistula tract and promote healing while safeguarding anal continence. The purpose of this prospective, single-arm clinical study is to evaluate the efficacy and safety of the two-stage seton re-routing technique in adult patients diagnosed with high perianal fistula at Assiut University Hospital. The procedure is conducted in two stages:

  • First Stage: Identification and curettage of the fistula tract followed by placement of a loose draining seton to clear local sepsis and allow fibrous maturation over an interval of 6 to 12 weeks.
  • Second Stage: Creation of a low submucosal or intersphincteric tunnel beneath the main external anal sphincter complex. The seton is unthreaded and re-routed through this lower pathway, isolating the upper transsphincteric tract so it can heal spontaneously by secondary fibrosis. The resulting downstaged superficial tract is then laid open (low fistulotomy) or managed with staged seton tightening. Participants will be monitored weekly during the first month, followed by regular monthly follow-up visits for a minimum of 6 to 9 months postoperatively. The study assesses complete fistula healing, recurrence rates, healing time, operative duration, postoperative complications, and anal continence status evaluated using the Cleveland Clinic (Wexner) Incontinence Score preoperatively and at 3, 6, and 9 months after surgery.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
13mo left

Started Oct 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Oct 2026Nov 2027

First Submitted

Initial submission to the registry

September 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 30, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

September 30, 2026

Status Verified

September 1, 2026

Enrollment Period

1 year

First QC Date

September 24, 2026

Last Update Submit

September 24, 2026

Conditions

Keywords

Seton re-routingLoose setonSphincter-sparing surgeryHigh transsphincteric fistulaAnal continenceWexner incontinence scoreFistulotom

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Complete Fistula Healing

    Complete fistula healing is defined as complete epithelialization and closure of both external and internal openings, with absence of discharge, pain, and induration on clinical examination.

    9 months

Study Arms (1)

Two-Stage Seton Re-routing

EXPERIMENTAL

Participants undergo a two-stage seton re-routing procedure: (1) Stage 1: Under spinal or general anesthesia, identification and curettage of the tract followed by loose draining seton placement through the high fistula tract for 6-12 weeks to control sepsis and allow fibrotic maturation. (2) Stage 2: An incision is made in the intersphincteric plane beneath the main external anal sphincter body to create a low submucosal or intersphincteric tunnel toward the dentate line. The seton is untied and re-routed through this low pathway, isolating the high transsphincteric component to heal by secondary fibrosis. The resulting downstaged low superficial tract is either laid open immediately (low fistulotomy) or managed with staged seton tightening.

Procedure: Seton Re-routing

Interventions

A two-stage sphincter-sparing surgical procedure: Stage 1: Under spinal or general anesthesia, identification and curettage of the tract, followed by placement of a loose draining seton through the high fistula tract for 6 to 12 weeks to control local sepsis and promote fibrotic maturation. Stage 2: An incision is made in the intersphincteric plane beneath the main external anal sphincter body to create a low submucosal or intersphincteric tunnel toward the dentate line. The seton is untied and re-routed through this lower pathway, isolating the high transsphincteric component to heal spontaneously by secondary fibrosis. The resulting downstaged low tract is either laid open immediately (low fistulotomy) or managed by staged seton tightening.

Two-Stage Seton Re-routing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older, of either sex.
  • Diagnosed with high perianal fistula (fistula tract involving the upper two-thirds of the external anal sphincter).
  • De novo or recurrent perianal fistula.
  • American Society of Anesthesiologists (ASA) physical status classification I or II.

You may not qualify if:

  • Fistula secondary to inflammatory bowel disease (Crohn's disease or ulcerative colitis), malignancy, tuberculosis, trauma, or prior pelvic irradiation.
  • Pre-existing fecal incontinence.
  • Uncontrolled diabetes mellitus or immunosuppressive conditions impairing wound healing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Rectal Fistula

Condition Hierarchy (Ancestors)

Intestinal FistulaDigestive System FistulaDigestive System DiseasesIntestinal DiseasesGastrointestinal DiseasesRectal DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident

Study Record Dates

First Submitted

September 24, 2026

First Posted

September 30, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

September 30, 2026

Record last verified: 2026-09